Daniel Farraye is an associate in Morrison Foerster’s Litigation Department and a member of the firm’s Global Antitrust Law Practice Group. His work focuses on antitrust and competition matters, including mergers and acquisitions, regulatory compliance, and complex litigation.

Daniel advises public and private companies on antitrust considerations arising from proposed transactions, including pre-merger planning and regulatory requirements under the Hart-Scott-Rodino Act. He has experience working with clients across a range of industries, including life sciences, healthcare, and technology.

His practice also encompasses antitrust and complex commercial litigation in federal courts. His experience spans the various stages of litigation, from discovery and witness preparation to evidentiary hearings, trial proceedings, and appeals. He has drafted substantive motions and appellate briefs, participated in witness examinations, and assisted with trial and appellate preparation.

Daniel earned his J.D. from William & Mary Law School, where he worked on the William & Mary Business Law Review. He received his B.S. in Biomedical Sciences from the University of Central Florida.